Ketogenic therapy for schizophrenia: evidence, mechanisms, and clinical perspectives
Cristiano Chaves(Queen's University), Elisa Brietzke(Queen's University), Mauro Giovanni Carta(University of Cagliari), Jennifer Fabe(McMaster Children's Hospital), Heather E. McNeely(Centre for Addiction and Mental Health), Serdar Dursun(University of Alberta), Fabiano A. Gomes(McMaster University), Jaime E. C. Hallak(Universidade de Ribeirão Preto), Massimo Tusconi(University of Cagliari)
Cited by 7
Related Papers
Deep Brain Stimulation for Treatment-Resistant Depression
|Neuron|2005|4.1k
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
|American Journal of Psychiatry|2016|1.1k
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
|Psychological Medicine|2018|819
Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
|Neuropsychopharmacology|2011|763
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
|Journal of Psychopharmacology|2010|530